Stay updated on Sparsentan in IgA Nephropathy: Clinical Trial

Sign up to get notified when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sparsentan in IgA Nephropathy: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added new trial locations across the United States, Australia, and Europe and removed several existing locations, altering the geographic availability of study sites. This affects where participants can enroll and access the trial.
    Difference
    3%
    Check dated 2025-12-23T20:27:56.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Publications section now states that PubMed publications are automatically filled, and the page revision is updated to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-24T20:56:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removal of an administrative funding-status notice from the page. The study details, eligibility criteria, primary and secondary outcomes, and listed locations remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-17T18:16:30.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    No significant changes were detected between the two screenshots; the page content and layout appear unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T12:49:06.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a site operation notice, introduced a new disease resource (IgA glomerulonephritis), and updated revision to v3.2.0 while removing v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T17:30:48.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.0%
    Check dated 2025-09-28T10:15:11.000Z thumbnail image

Stay in the know with updates to Sparsentan in IgA Nephropathy: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.